Pay in 4 interest-free payments of $26.77 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
A comparative study of their rates of beta-oxidation and esterification of palmitate and their sensitivity to R-etomoxir
FSCPX irreversible A1 adenosine receptor antagonist
Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives
Smiles: COC1C=CC(CN2C(=O)N=C3C2=NC=NC2=C3N=CN2CC2C=CC(=CC=2)OC)=CC=1
LCL161 Size:Solid 10 mg A comparative study of theirLCL161 is a n orally bioavailable second mitochondrial derived activator of caspases (SMAC) mimetic and inhibitor of IAP (Inhibitor of Apoptosis Protein) family of proteins, with potential antineoplastic activity. SMAC mimetic LCL161 binds to IAPs, such as X chromosome linked IAP (XIAP) and cellular IAPs 1 and 2. Since IAPs shield cancer cells from the apoptosis process, this agent may restore and promote the induction of apoptosis through apoptotic